HF
HOOK

HRT Financial’s HOOKIPA Pharma HOOK Stock Holding History

HRT Financial’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,309
Closed -$22K – 2871
2024
Q4 		$22K Buy
+11,309
New +$35K ﹤0.01% 2193
2024
Q2 		– Sell
-3,487
Closed -$24K – 2575
2024
Q1 		$24K Buy
+3,487
New +$24.8K ﹤0.01% 1994
2023
Q3 		– Sell
-2,362
Closed -$20K – 2690
2023
Q2 		$20K Buy
+2,362
New +$26.2K ﹤0.01% 2099

Other funds holding HOOK

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRT Financial's HOOK Position: Q1 2025 in Review

HRT Financial sold out of HOOKIPA Pharma (HOOK) in Q1 2025, closing a stake of 11,309 shares — an estimated $22K sold.

HRT Financial first reported a position in HOOK in Q2 2023 and held it in 3 quarters. The position peaked at $24K in Q1 2024. 32 funds tracked by Wall St. Rank hold HOOK as of Q1 2025.

  • HRT Financial reported no remaining HOOKIPA Pharma position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 11,309 HOOKIPA Pharma shares in Q1 2025, an estimated $22K.
  • HRT Financial first reported a position in HOOKIPA Pharma in Q2 2023 and held it in 3 quarters.
  • HRT Financial's HOOKIPA Pharma position peaked at $24K in Q1 2024.
  • 32 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.